Efficacy and Safety of First-Line Carboplatin- versus Cisplatin-based Chemotherapy for Non-Small Cell Lung Cancer: A Meta-Analysis

Title
Efficacy and Safety of First-Line Carboplatin- versus Cisplatin-based Chemotherapy for Non-Small Cell Lung Cancer: A Meta-Analysis
Authors
Keywords
Non-small cell lung cancer, Platinum doublet, Cisplatin, Carboplatin, Meta-analysis
Journal
LUNG CANCER
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2019-07-13
DOI
10.1016/j.lungcan.2019.07.010

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started